TOA Paint (Thailand) PCL (BKK:TOA)

SpringWorks Therapeutics Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	21,130	21,140	22,279	20,649	17,570	16,296
Revenue	21,130	21,140	22,279	20,649	17,570	16,296
Revenue Growth (YoY)	-4.20%	-5.11%	7.89%	17.52%	7.82%	-4.02%
Cost of Revenue	13,755	13,836	14,745	14,646	11,823	10,287
Gross Profit	7,374	7,304	7,534	6,003	5,747	6,009
Selling, General & Admin	4,459	4,480	4,313	4,008	3,509	3,510
Operating Expenses	4,459	4,480	4,313	4,008	3,509	3,510
Operating Income	2,916	2,824	3,221	1,995	2,238	2,499
Interest Expense	-52.42	-55.26	-41.91	-38.19	-34.81	-38.76
Interest & Investment Income	101.98	101.69	74.42	48.24	51.23	42.01
Currency Exchange Gain (Loss)	-581.41	-388.1	-71.69	-146.84	50.79	27.95
Other Non Operating Income (Expenses)	107.32	115.36	125.27	128.46	86.34	100.19
EBT Excluding Unusual Items	2,491	2,598	3,308	1,987	2,391	2,630
Impairment of Goodwill	-19.21	-19.21	-	-	-	-
Gain (Loss) on Sale of Investments	19.62	39.94	22.89	-107.06	69.21	-35.24
Asset Writedown	-	-	-	6.31	-6.31	-
Pretax Income	2,492	2,619	3,330	1,886	2,454	2,595
Income Tax Expense	598.66	643.7	693.73	452.24	528.04	570.5
Earnings From Continuing Operations	1,893	1,975	2,637	1,434	1,926	2,025
Net Income to Company	1,893	1,975	2,637	1,434	1,926	2,025
Minority Interest in Earnings	-44.34	-55.49	-67.47	-16.35	28.78	6.45
Net Income	1,849	1,920	2,569	1,417	1,955	2,031
Net Income to Common	1,849	1,920	2,569	1,417	1,955	2,031
Net Income Growth	-32.56%	-25.29%	81.29%	-27.51%	-3.75%	-6.07%
Shares Outstanding (Basic)	1,997	2,008	2,029	2,029	2,029	2,029
Shares Outstanding (Diluted)	1,997	2,008	2,029	2,029	2,029	2,029
Shares Change (YoY)	-1.57%	-1.05%	-	-	-	-
EPS (Basic)	0.93	0.96	1.27	0.70	0.96	1.00
EPS (Diluted)	0.93	0.96	1.27	0.70	0.96	1.00
EPS Growth	-31.49%	-24.49%	81.29%	-27.51%	-3.75%	-6.07%
Free Cash Flow	2,018	2,193	2,750	852	2,260	1,614
Free Cash Flow Per Share	1.01	1.09	1.35	0.42	1.11	0.80
Dividend Per Share	0.600	0.600	0.680	0.500	0.500	0.530
Dividend Growth	-11.77%	-11.77%	36.00%	-	-5.66%	6.00%
Gross Margin	34.90%	34.55%	33.82%	29.07%	32.71%	36.88%
Operating Margin	13.80%	13.36%	14.46%	9.66%	12.74%	15.33%
Profit Margin	8.75%	9.08%	11.53%	6.86%	11.13%	12.46%
Free Cash Flow Margin	9.55%	10.38%	12.34%	4.13%	12.86%	9.90%
EBITDA	3,357	3,321	3,667	2,425	2,614	2,875
EBITDA Margin	15.89%	15.71%	16.46%	11.74%	14.88%	17.64%
D&A For EBITDA	440.97	496.99	445.22	429.95	376.45	375.8
EBIT	2,916	2,824	3,221	1,995	2,238	2,499
EBIT Margin	13.80%	13.36%	14.46%	9.66%	12.74%	15.33%
Effective Tax Rate	24.03%	24.58%	20.83%	23.98%	21.52%	21.98%
Advertising Expenses	-	616.17	639.14	631.97	497.62	590.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.